Boehringer Ingelheim France Boehringer Ingelheim Pharma GmbH & Co. KG

Poland

All drugs from this manufacturer

  • ACTILYSE 10

    The medicine is used to dissolve blood clots in blood vessels. It is intended for the treatment of acute myocardial infarction, massive acute pulmonary embolism, and acute ischaemic stroke caused by a clot in a cerebral artery.

    Dosage form: powder and solvent for preparation of infusion solution

    Active substance Dosage
    alteplase 10 mg

    ATC: B01AD02

  • ACTILYSE 20

    The medicine is used to treat disorders caused by blood clots in the blood vessels, such as acute myocardial infarction, massive acute pulmonary embolism, and acute ischemic stroke.

    Dosage form: powder and solvent for preparation of infusion solution

    Active substance Dosage
    alteplase 20 mg

    ATC: B01AD02

  • ACTILYSE 50

    The medicine is used to dissolve blood clots in the blood vessels. It is intended for the treatment of acute myocardial infarction, acute massive pulmonary embolism, and acute ischaemic stroke caused by a clot in a cerebral artery.

    Dosage form: powder and solvent for preparation of infusion solution

    Active substance Dosage
    alteplase 50 mg

    ATC: B01AD02

  • SPIRIVA

    The medicine makes breathing easier for people with chronic obstructive pulmonary disease (COPD). It helps to dilate the airways, which facilitates airflow to the lungs, reduces shortness of breath, and may prevent sudden worsening of health status.

    Dosage form: powder for inhalation in hard capsules

    Active substance Dosage
    tiotropium bromide monohydrate 22.5 mcg

    ATC: R03BB04